{"url_path":"/fda/drug/recalls/D-0547-2026","section_key":"summary","section_title":"DRUG Recall: Ascend Laboratories, LLC — Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-04-27","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0547-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Ascend Laboratories, LLC"},"word_count":73,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0547-2026\n\n**Recalling firm:** Ascend Laboratories, LLC\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-04-27\n**Report date:** 2026-05-20\n\n## Product\nAscend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.\n\n## Reason\nFailed Dissolution Specifications\n\n## Affected lots\nLot # 25140859; Exp. Date: Jan 2027\n\n## Distribution\nU.S. Nationwide"}